Efficacy and safety of catheter ablation for paroxysmal atrial fibrillation: A comparison of first-line vs second-line therapy.
Jun Oikawa, Hidehira Fukaya, Koshiro Kanaoka...
https://pubmed.ncbi.nlm.nih.gov/40714332/Actively Recruiting
Led by National Cerebral and Cardiovascular Center, Japan · Updated on 2023-11-13
400000
Participants Needed
1
Research Sites
N/A
Total Duration
The Japanese Catheter Ablation J-AB Registry is a nationwide observational study conducted by the Japanese Heart Rhythm Society in collaboration with the National Cerebral and Cardiovascular Center. It aims to track and describe the progress and activity of catheter ablation treatments for cardiac arrhythmias across Japan. The study collects data to provide reliable information on treatment types and available facilities in arrhythmia units nationwide. Data are collected prospectively using an electronic system, including detailed information on antiarrhythmic medications gathered annually each September. The registry records the success rate of ablation procedures at hospital discharge and monitors complications, including major bleeding events. An event assessment committee evaluates the annual incidence and predictive factors related to outcomes. Participants contribute data on their catheter ablation treatment, with researchers recording outcomes such as arrhythmia recurrence up to one week after hospital discharge. Additional follow-up tracks deaths and treatment-related complications up to three months. The study is ongoing, with data collection supporting continuous monitoring of catheter ablation practices and patient outcomes in Japan.
CONDITIONS
Japanese Catheter Ablation Registry
K
Kengo Kusano, MD, PhD
M
Misa Takegami, PhD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Cerebral and Cardiovascular Center, Japan
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Not specified
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 week through hospital discharge
Participants who undergo catheter ablation as part of routine healthcare are observed for outcomes related to the procedure.
1 hospitalization period including the ablation procedure
Duration - 3 months
Participants are monitored for treatment-related complications and outcomes after discharge.
Follow-up visits as per routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Jun Oikawa, Hidehira Fukaya, Koshiro Kanaoka...
https://pubmed.ncbi.nlm.nih.gov/40714332/Yasuhiro Matsuda, Masaharu Masuda, Koshiro Kanaoka...
https://pubmed.ncbi.nlm.nih.gov/40995616/Kentaro Goto, Shinsuke Miyazaki, Reina Tonegawa-Kuji...
https://pubmed.ncbi.nlm.nih.gov/40861252/National Cerebral and Cardiovascular Center, Japan
Lead Sponsor